Summary
Hexarelin and Selank are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Hexarelin is more often discussed in the realm of Metabolic and endocrine and Cardiovascular health, whereas Selank is more often associated with the realm of Neurology and brain health and Immunology and inflammation. They also influence different molecular systems, with Hexarelin tracking more closely to Ghrelin receptor while Selank centers more on GPCR receptor. Hexarelin has a more synthetic design origin, while Selank is closer to synthetic analog background with Hexarelin in Preclinical development and Selank approved for Research use only. Hexarelin incorporates d-amino acid substitution and amidation features that are not part of Selank, while their sequence patterns also diverge, with Hexarelin showing protein-mimetic sequence features and Selank showing proline-rich features.